Product Research and Development and Value Creation Based on Customer Needs
First written in FY2016. 13 of 14 entries say "Restated". Latest entry: FY2025.
3 other companies' latest entry also says "Restated".
- FY2025RestatedAnnual report
「As the operating environment continues to change amid unstable international conditions, our basic policy is to conduct R&D on products that meet diverse, increasingly sophisticated customer needs across a wide range of areas and to pursue value creation.」
The company continues to pursue R&D and value creation tailored to customer needs as its basic policy, taking international conditions and changes in the operating environment into account. - FY2022RestatedAnnual report
「As a manufacturer and seller of medical devices in the vascular and blood-related fields, the Group has developed products tailored to the needs of medical settings in 3 product categories—artificial dialysis products, indwelling venous needles and interventional products—and has provided them as safe, high-quality products, building the trust of healthcare professionals.」
The company has reaffirmed product development tailored to the needs of medical settings and value creation through safe, high-quality products as its business policy across its 3 product categories. - FY2021RestatedAnnual report
「As a manufacturer and seller of medical devices in the vascular and blood-related fields, the Group has developed products tailored to the needs of medical settings in 3 product categories—artificial dialysis products, indwelling venous needles and interventional products—and has provided them as safe, high-quality products, building the trust of healthcare professionals.」
The company continues to develop products tailored to the needs of medical settings and create value through safe, high-quality products. - FY2020-Q3RestatedAnnual report
「Against this backdrop, the Group has worked to provide high-quality products to medical professionals and to propose new products with the safety features needed to address advances in medical care.」
The company continues to pursue the provision of high-quality products to medical settings and the proposal of safe new products addressing advances in medicine as its R&D and value creation policy. - FY2020-Q2RestatedAnnual report
「Against this backdrop, the Group has worked to provide high-quality products to medical professionals and to propose new products with the safety features needed to address advances in medical care.」
The company continues to pursue the provision of products to medical settings and the proposal of safe new products addressing advances in medicine as its R&D and value creation policy. - FY2020-Q1RestatedAnnual report
「Against this backdrop, the Group has worked to provide high-quality products to medical professionals and to propose new products with the safety features needed to address advances in medical care.」
The company continues to pursue the provision of products to medical settings and the proposal of safe new products addressing advances in medicine as its R&D and value creation policy. - FY2019-Q3RestatedAnnual report
「Against this backdrop, the Group has worked to provide high-quality products to medical professionals and to provide new products with the safety features needed to address advances in medical care.」
The company continues to pursue the provision of products to medical settings and the development of new products addressing advances in medicine as its R&D and value creation policy. - FY2019-Q2RestatedAnnual report
「Against this backdrop, the Group has worked to provide high-quality products to medical professionals and to provide new products with the safety features needed to address advances in medical care.」
The company continues to pursue the provision of products to medical settings and the development of new products addressing advances in medicine as its R&D and value creation policy. - FY2019-Q1RestatedAnnual report
「Against this backdrop, the Group has worked to provide high-quality products to medical professionals and to provide new products with the safety features needed to address advances in medical care.」
The company continues to pursue the provision of products to medical settings and the development of new products addressing advances in medicine as its R&D and value creation policy. - FY2018RestatedAnnual report
「Amid major changes in the operating environment, the Group's basic policy is to conduct R&D on products that meet diverse, increasingly sophisticated customer needs across a broad range of areas and to pursue value creation.」
The company has reaffirmed R&D and value creation tailored to customer needs as its basic R&D policy. - FY2018-Q3RestatedAnnual report
「Against this backdrop, the Group has worked to provide high-quality products to medical professionals and to propose new products with the safety features needed to address advances in medical care.」
The company continues to describe the provision of products to medical settings and the proposal of new products addressing advances in medicine. - FY2018-Q2RestatedAnnual report
「Against this backdrop, the Group has worked to provide high-quality products to medical professionals and to propose new products with the safety features needed to address advances in medical care.」
The company continues to describe the provision of products to medical settings and the proposal of new products addressing advances in medicine. - FY2018-Q1RestatedAnnual report
「Against this backdrop, the Group has worked to provide high-quality products to medical professionals and to propose new products with the safety features needed to address advances in medical care.」
The company continues to describe the provision of products to medical settings and the proposal of new products addressing advances in medicine. - FY2016First statedAnnual report
「Amid major changes in the operating environment, the Group's basic policy is to conduct R&D on products that meet diverse, increasingly sophisticated customer needs across a broad range of areas and to pursue value creation.」
The company makes addressing customer needs and creating value its basic R&D policy.